Literature DB >> 30633325

Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing.

Stephen Grant1, Mona Kamal1, Abdallah S R Mohamed1,2, Jhankruti Zaveri3, Martha P Barrow3, G Brandon Gunn1, Stephen Y Lai3, Jan S Lewin3, David I Rosenthal1, Xin Shelley Wang4, Clifton D Fuller1, Katherine A Hutcheson3.   

Abstract

BACKGROUND: Two patient-reported outcomes (PROs) of swallowing and their correlation to quality of life (QOL) were compared in long-term survivors of oropharyngeal cancer (OPC).
METHODS: Scores on the single dysphagia item from the 28-item, multisymptom MD Anderson Symptom Inventory-Head and Neck (MDASI-HN-S) were compared with scores on the dysphagia-specific composite MD Anderson Dysphagia Inventory (MDADI) and the EuroQol visual analog scale (EQ-VAS) in 714 patients who had received definitive radiotherapy ≥12 months before the survey. An MDASI-HN-S score ≥6 and an MDADI composite score <60 were considered representative of moderate/severe swallowing dysfunction.
RESULTS: Moderate/severe dysphagia was reported by 17% and 16% of respondents on the MDASI-HN-S and the composite MDADI, respectively. Both swallow PROs were predictive of QOL, and the MDASI-HN-S model was slightly more parsimonious for the discrimination of EQ-VAS scores compared with MDADI scores (Bayesian information criteria, 6062 vs 6076, respectively). An MDASI-HN-S cutoff score of ≥6 correlated best with a declining EQ-VAS score (P < .0001) and was associated with increased radiotherapy dose to several normal swallowing structures.
CONCLUSIONS: In this cohort, the single-item MDASI-HN-S performed favorably for the discrimination of QOL compared with the multi-item MDADI. A time-efficient model for PRO measurement of swallowing is proposed in which the MDADI may be reserved for patients who score ≥6 on the MDASI-HN-S.
© 2019 American Cancer Society.

Entities:  

Keywords:  dysphagia; oropharynx cancer; patient-reported outcomes; quality of life; radiotherapy

Mesh:

Year:  2019        PMID: 30633325      PMCID: PMC6486422          DOI: 10.1002/cncr.31957

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Perioperative symptom burden and its influencing factors in patients with oral cancer: A longitudinal study.

Authors:  Meijun Ou; Guifen Wang; Yixia Yan; Hong Chen; Xianghua Xu
Journal:  Asia Pac J Oncol Nurs       Date:  2022-04-23

2.  Comparison of Bazaz scale, Dysphagia Short Questionnaire, and Hospital for Special Surgery-Dysphagia and Dysphonia Inventory for Assessing Dysphagia Symptoms After Anterior Cervical Spine Surgery in Chinese Population.

Authors:  Guoyan Liang; Xiaoqing Zheng; Changxiang Liang; Chong Chen; Yongxiong Huang; Shuaihao Huang; Yunbing Chang
Journal:  Dysphagia       Date:  2021-03-04       Impact factor: 3.438

3.  A longitudinal study of the Swedish MD Anderson Dysphagia Inventory in patients with oral cancer.

Authors:  Lisa Tuomi; Per Fransson; Johan Wennerberg; Caterina Finizia
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-11-03

4.  Predictors of severe dysphagia following radiotherapy for head and neck cancer.

Authors:  Kerstin Petersson; Caterina Finizia; Lisa Tuomi
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-10-02

5.  Dysphagia, trismus and speech impairment following radiation-based treatment for advanced stage oropharyngeal carcinoma: a one-year prospective evaluation.

Authors:  Rebecca T Karsten; Najiba Chargi; Lisette van der Molen; Rob J J H van Son; Remco de Bree; Abrahim Al-Mamgani; Jan P de Boer; Frans J M Hilgers; Michiel W M van den Brekel; Ludi E Smeele; Martijn M Stuiver
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-05-27       Impact factor: 2.503

6.  The effect of the Shaker head-lift exercise on swallowing function following treatment for head and neck cancer: Results from a randomized, controlled trial with videofluoroscopic evaluation.

Authors:  Lisa Tuomi; Hans Dotevall; Henrik Bergquist; Kerstin Petersson; Mats Andersson; Caterina Finizia
Journal:  Head Neck       Date:  2022-01-23       Impact factor: 3.821

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.